ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,220Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 336

$900K Total Retail Price of All Prescriptions

Rank: 54 out of 336

493 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 11,161 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
CARVEDILOL 635 508 1 13
SIMVASTATIN 601 457 2 5
AMLODIPINE BESYLATE 505 359 3 1
ATORVASTATIN CALCIUM 417 298 4 14
METFORMIN HCL 413 300 5 8
OMEPRAZOLE 407 326 6 3
LISINOPRIL 387 257 7 6
FUROSEMIDE 381 342 8 4
HYDROCHLOROTHIAZIDE 310 219 9 12
POTASSIUM CHLORIDE 290 234 10 9
RAMIPRIL 265 191 11 84
NAMENDA 205 197 12 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 186 91 13 23
GABAPENTIN 180 144 14 11
WARFARIN SODIUM 172 139 15 17
ZOLPIDEM TARTRATE 165 95 16 18
DONEPEZIL HCL 158 158 17 27
HYDROCODONE-ACETAMINOPHEN 156 66 S3 18 2
METOPROLOL TARTRATE 135 94 19 16
OXYCODONE-ACETAMINOPHEN 133 82 S2 20 191
ADVAIR DISKUS 132 95 21 82
CLOPIDOGREL 132 97 21 28
TRAMADOL HCL 129 114 23 20
LIPITOR 126 89 24 62
ACTOS 124 85 25 119
LANTUS 122 80 26 56
AZITHROMYCIN 120 83 27 58
DICLOFENAC POTASSIUM 118 67 28 318
LEVOTHYROXINE SODIUM 116 98 29 7
AMLODIPINE BESYLATE-BENAZEPRIL 114 90 30 47
GLIMEPIRIDE 113 99 31 29
LYRICA 111 68 32 70
PREDNISONE 110 62 33 48
ACTOPLUS MET 110 83 33 275
NEXIUM 109 72 35 24
TAMSULOSIN HCL 108 103 36 38
BENAZEPRIL-HYDROCHLOROTHIAZIDE 108 94 36 207
DIOVAN HCT 104 102 38 41
PHENYTOIN SODIUM EXTENDED 103 71 39 97
ATENOLOL 102 76 40 26
ALLOPURINOL 97 94 41 30
BENAZEPRIL HCL 95 83 42 59
CYCLOBENZAPRINE HCL 95 40 R 42 65
DIOVAN 93 74 44 31
FAMOTIDINE 93 66 44 73
INSULIN SYRINGE 92 42 46 102
SERTRALINE HCL 89 64 47 33
POLYETHYLENE GLYCOL 3350 88 75 48 68
PLAVIX 88 69 48 37
ALENDRONATE SODIUM 86 69 50 54
PROAIR HFA 86 25 50 77
LOSARTAN POTASSIUM 83 52 52 22
HYDRALAZINE HCL 83 59 52 53
PANTOPRAZOLE SODIUM 82 59 54 40
PAROXETINE HCL 82 60 54 64
CLONIDINE HCL 81 55 56 32
ESCITALOPRAM OXALATE 80 61 57 69
DIGOXIN 78 44 58 50
MELOXICAM 77 57 59 19
MEGESTROL ACETATE 73 68 R 60 110
QUETIAPINE FUMARATE 72 65 61 94
ATENOLOL-CHLORTHALIDONE 71 60 62 200
CIPROFLOXACIN HCL 71 56 62 55
NIFEDIPINE ER 69 48 64 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 51 65 89
CITALOPRAM HBR 66 56 66 21
METOPROLOL SUCCINATE 64 54 67 15
OXYCODONE HCL-ACETAMINOPHEN 61 30 S2 68 136
FLUTICASONE PROPIONATE 61 48 68 49
LEVEMIR 60 31 70 149
CELEBREX 60 56 70 105
DOXAZOSIN MESYLATE 60 51 70 86
VENLAFAXINE HCL ER 57 43 73 100
BUSPIRONE HCL 56 47 74 113
DIVALPROEX SODIUM 55 12 75 142
GLIPIZIDE XL 54 35 76 174
CYMBALTA 54 46 76 52
RISPERIDONE 54 42 76 90
LOVASTATIN 53 35 79 34
LEVETIRACETAM 51 40 80 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.